Cryoport (CYRX) Liabilities and Shareholders Equity (2011 - 2026)

Cryoport (CYRX) has reported Liabilities and Shareholders Equity for 16 consecutive years, with $763.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 9.11% year-over-year to $763.6 million; the TTM figure through Mar 2026 stood at $3.1 billion (up 4.04% YoY), while the FY2025 annual figure was $765.0 million, up 8.74% from the prior year.
• Liabilities and Shareholders Equity steadied at $763.6 million in Q1 2026 per CYRX's latest filing, from $765.0 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $1.1 billion in Q1 2022 and bottomed at $699.8 million in Q1 2025.
• Historically, Liabilities and Shareholders Equity has averaged $895.0 million across 5 years, with a median of $942.8 million in 2024.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity jumped 31.92% — and 2024, when it declined 29.87%.
• Cryoport's Liabilities and Shareholders Equity stood at $1.0 billion in 2022, then retreated by 7.8% to $957.7 million in 2023, then dropped by 26.55% to $703.5 million in 2024, then gained by 8.74% to $765.0 million in 2025, then decreased by 0.18% to $763.6 million in 2026.
• Business Quant data shows CYRX's Liabilities and Shareholders Equity at $763.6 million in Q1 2026, $765.0 million in Q4 2025, and $774.3 million in Q3 2025.